Abbott Axsym Beta-HCG Pregnancy Test: Overview

RSS
Modified on 2009/10/14 21:45 by admin
Abbott Laboratories' Axsym Beta-HCG pregnancy test is one of the most commonly used blood pregnancy tests in the country. The test measures the beta human chorionic gonadotropin (HCG) hormone. Elevated HCG levels can mean a woman is pregnant. Unfortunately, high levels of HCG may also indicate gestational trophoblastic tumor, a rare form of cancer.

Utilizing the Abbott test can be dangerous for an estimated ten percent of women whose blood contains natural substances that may skew the results. According to doctors, a healthy woman may show high levels of HCG in the test, while showing no signs of fetal development. Such an outcome could result in the misdiagnoses of a gestational trophoblastic tumor. Because this type of cancer spreads rapidly, it is necessary to treat early. As such, some doctors will begin chemotherapy based on the Abbott test alone, even without other evidence of a tumor.

Jennifer Rufer, 22, was the victim of this unfortunate scenario when a misdiagnosis led to chemotherapy and eventually a hysterectomy. In reality, Rufer never had a gestational trophoblastic tumor, or any other type of cancer. Rufer recently won a $16 million lawsuit against Abbott Laboratories and the medical center that used the test. Since Rufer shared her story, dozens of other women have come forward who suffered the same problem. Abbott Laboratories is in the process of reminding doctors of the pregnancy test's limitations.

See your doctor if you have experienced serious health problems after using the Abbott test. In addition, it may be important to contact an attorney who can help you protect your legal rights. Please keep in mind that there may be time limits within which you must commence suit.



See Also

  1. Medical Devices & Implants
  Name Size